Tyrosinemia type III is a very rare inherited condition in which the body cannot fully break down the amino acid tyrosine. It is usually recognized in infancy or childhood, but some people with Tyrosinemia type III have few or no clear problems. Signs can include developmental delay, learning difficulties, seizures, and trouble with balance or coordination. Tyrosinemia type III is lifelong, and not everyone will have the same experience. Treatment usually focuses on a low-tyrosine and low-phenylalanine diet, often with special medical formula, and many living with Tyrosinemia type III may benefit most when early symptoms of Tyrosinemia type III are assessed promptly by a specialist.
How many people live with Tyrosinemia type iii?
There is no reliable published estimate of how many people are living with tyrosinemia type III worldwide or in the United States. The condition is extremely rare, and only a very small number of cases have been described in medical reports, so experts do not have a dependable current head count for either group.
Overview
Tyrosinemia type iiiSymptoms
Tyrosinemia type III may cause seizures, learning delays, or trouble with balance and coordination. Some people have mild signs or none at all. Features often begin in infancy or early childhood.
Outlook and prognosis
Tyrosinemia type iii is rare, and outlook varies widely. With early treatment to keep tyrosine levels down and regular follow-up, many people with tyrosinemia type iii do well, though some may have learning, balance, or seizure-related challenges.
Causes and risk factors
Tyrosinemia type III is caused by changes in the HPD gene, usually inherited from both parents. Family history raises the chance, while diet and other outside factors do not cause it, though they may affect symptoms and complications.
Genetic influences
Genetics are central to Tyrosinemia type iii. It is caused by changes in the HPD gene, usually inherited from both parents. Genetic testing can confirm Tyrosinemia type iii and help with family planning.
Diagnosis
Tyrosinemia type iii is usually suspected from symptoms and blood or urine tests showing high tyrosine levels. Doctors then confirm the diagnosis of Tyrosinemia type iii with genetic tests. In some cases, liver tests or imaging help rule out other causes.
Treatment and drugs
Tyrosinemia type iii is usually treated with a low-tyrosine, low-phenylalanine diet, often using special medical formula. Many living with tyrosinemia type iii also need regular blood tests and follow-up to help prevent nerve-related symptoms and support growth.
Symptoms
Tyrosinemia type III can look very different from one person to another. For many people with Tyrosinemia type III, the main concerns involve the brain and nervous system rather than obvious physical changes. In some cases, the early features of Tyrosinemia type III are noticed because a child is developing more slowly than expected, while others have few or no day-to-day problems.
Some children reach milestones like sitting, walking, or talking later than expected. Day to day, this can mean needing extra help with speech, movement, or learning.
Some people with Tyrosinemia type III have trouble with learning, attention, or memory, and some have intellectual disability. The range is wide, so support needs can be mild or more significant.
Seizures can occur in some people living with Tyrosinemia type III. They may look like staring spells, body stiffening, jerking movements, or episodes of unresponsiveness.
Balance and coordination problems can make walking look unsteady or clumsy. Some may find stairs, sports, or quick changes in direction harder than expected.
How people usually first notice Tyrosinemia type iii?
Tyrosinemia type III is usually first noticed in infancy or early childhood, often when a baby or young child has developmental delay, trouble with balance or coordination, or seizures that lead doctors to look more closely. In some families, the first signs of tyrosinemia type III are not obvious symptoms at all, but an abnormal newborn screening result or blood test showing high tyrosine, an amino acid, before a child seems unwell. Because this condition is very rare and some people have few or no symptoms, how tyrosinemia type III is first noticed can vary, but it often begins with early neurologic or developmental concerns rather than a single clear warning sign.
Types of Tyrosinemia type iii
No distinct types of Tyrosinemia type III are widely recognized.
Can I slow down the onset of symptoms?
Not really in the usual lifestyle sense: tyrosinemia type III is a rare inherited condition present from birth, and there is no strong evidence that exercise, sleep, supplements, or other general health habits can meaningfully delay when symptoms start. The main step that may help is early medical care to keep certain protein building blocks in the blood, especially tyrosine, from getting too high, often with a special diet; this may lower the risk of symptoms for some people, but it does not prevent the condition. Because this condition is so rare, research is limited, but getting early follow-up with a specialist can still give many living with tyrosinemia type III the best chance to stay well.
What genetics can tell you about symptoms
Genetics can explain part of why symptoms vary in tyrosinemia type III, but it does not predict everything with certainty. Changes in the HPD gene cause this condition, and different genetic variants may affect how much the enzyme still works, which can influence whether symptoms show up at all, how early they begin, and how severe problems such as developmental delay, learning difficulties, poor balance, or seizures may be. Even within the same family, though, people with tyrosinemia type III can have very different symptoms, so genetic results are helpful but do not give a full day-to-day forecast.
Causes and risk factors
Tyrosinemia type III happens when a child inherits changes in both copies of a gene called HPD, usually one from each parent. The main risk factors for tyrosinemia type III are having parents who each carry one changed copy of that gene and having a family history of the condition. It is also more common when parents are closely related by blood. A high-protein diet does not cause it, but it can raise tyrosine levels and make symptoms more likely to show. Risk can vary widely from person to person.
What are the most common causes or risk factors?
Tyrosinemia type III is almost always caused by inherited changes in a gene called HPD, which helps the body break down tyrosine, a natural part of protein in food. The main risk factors are having both parents carry one changed copy of this gene, having a family history of the condition, or having parents who are blood relatives, which makes it more likely a child will inherit two changed copies. There are no known lifestyle or environmental risk factors, so it is not caused by anything a parent did or did not do.
Environmental and biological risk factors
Tyrosinemia type III is a very rare condition that begins before birth. If you are reading about risk factors for tyrosinemia type III, the key point is that doctors have not identified clear environmental exposures or other well-proven biological triggers that reliably increase the chance of it occurring. Common pregnancy events also have not been linked to this condition in a consistent way.
No specific medicine, infection, toxin, or pollution exposure has been proven to cause tyrosinemia type III. For most families, there is no clearly identified outside trigger.
Maternal illness, parental age, and routine birth-related events are not established risk factors for tyrosinemia type III. Because the condition is so rare, research is limited, but current evidence has not shown a consistent pregnancy-related pattern.
Genetic risk factors
For families trying to understand why tyrosinemia type III happened, the main cause is an inherited change in a gene that helps the body process tyrosine, a building block from protein. Some risk factors are inherited through our genes. Tyrosinemia type III develops when both copies of the HPD gene are not working as they should, and the chance is higher when both biological parents carry one changed copy. Early symptoms of tyrosinemia type III can vary, so genetics often provides the clearest explanation of risk.
HPD gene: Tyrosinemia type III is caused by changes in the HPD gene. This gene helps break down tyrosine, and when it does not work properly, related chemicals can build up in the body.
Two copies: People with tyrosinemia type III usually inherit one changed HPD gene copy from each biological parent. Having only one changed copy usually means someone is a carrier rather than having the condition.
Carrier parents: If both biological parents are carriers, each pregnancy has a 1 in 4, or 25%, chance of tyrosinemia type III. The same pregnancy has a 1 in 2, or 50%, chance that the child will be a carrier.
Family history: A family history of tyrosinemia type III or known HPD gene changes raises the chance that the same change is present in other relatives. This can matter especially when a brother or sister is affected.
Related parents: The chance is higher when biological parents are closely related, such as first cousins. That is because relatives are more likely to carry the same rare HPD gene change.
Lifestyle risk factors
Tyrosinemia type III is an inherited disorder, so lifestyle habits do not cause it. However, how lifestyle affects tyrosinemia type III can matter for blood tyrosine levels, symptom control, and the risk of neurologic problems such as seizures or balance issues. The most important lifestyle-related factors are eating patterns, protein choices, and how closely the treatment plan is followed.
Eating too much natural protein can raise tyrosine levels because tyrosinemia type III affects tyrosine breakdown. This can make metabolic control harder and may increase the chance of neurologic symptoms in people who are sensitive to high tyrosine levels.
Frequent intake of foods high in tyrosine and phenylalanine, such as large amounts of meat, dairy, eggs, or protein-heavy processed foods, can worsen the biochemical imbalance. When a low-tyrosine, low-phenylalanine plan is prescribed, not following it is one of the main lifestyle risk factors for tyrosinemia type III.
Bodybuilding powders, amino acid mixes, and high-protein meal replacements can sharply increase the load of tyrosine-related amino acids. Using these products without metabolic guidance may push levels out of range even if regular meals seem controlled.
Skipping medical foods, special formulas, or the recommended meal structure can reduce nutritional balance while allowing tyrosine to build up. Long-term inconsistency may increase the risk of symptoms related to the brain and nervous system.
Risk prevention
Tyrosinemia type III is a rare inherited condition, so there is no proven way to prevent the condition itself if a child is born with the gene change. For many living with tyrosinemia type III, prevention means lowering the chance of symptoms and protecting the brain and overall health over time. This often centers on early diagnosis, regular follow-up, and careful control of protein building blocks in food, especially tyrosine and phenylalanine. Prevention works best when combined with regular check-ups.
Newborn screening or early testing in families at risk can help catch tyrosinemia type III before problems build up. Early treatment may lower the risk of developmental delays, seizures, or other early symptoms of tyrosinemia type III.
A low-tyrosine, low-phenylalanine eating plan can help keep harmful levels from rising. This usually means working closely with a metabolic dietitian so growth and nutrition stay on track.
Blood tests help monitor tyrosine levels and show whether the treatment plan is working. This can help doctors adjust diet early, before symptoms appear or worsen.
Ongoing care with a metabolic specialist helps watch for learning, movement, or seizure-related concerns linked to tyrosinemia type III. Some prevention is universal, others are tailored to people with specific risks.
Can you prevent Tyrosinemia type iii?
Tyrosinemia type III usually cannot be prevented, because it is a rare inherited condition that a child is born with and it is not caused by food, exercise, or other everyday habits. If it runs in your family, genetic counseling and testing before pregnancy can help you understand the chance of passing it on, but they cannot guarantee prevention.
Transmission
Tyrosinemia type III is not infectious, so it cannot spread from person to person through touch, the air, food, sex, or blood. Instead, the genetic transmission of Tyrosinemia type III happens when a child inherits two changed copies of the same gene, one from each parent.
Most parents are healthy carriers and do not know they carry the gene change. This pattern, known medically as autosomal recessive inheritance, means each pregnancy has a 25% chance of Tyrosinemia type III, a 50% chance of having a child who is a carrier, and a 25% chance of having a child who inherits neither changed copy.
When to test your genes
Consider genetic testing for tyrosinemia type III if a baby, child, or adult has high blood tyrosine with unexplained seizures, balance problems, or developmental delay, or if there is a known family history. Testing can confirm the diagnosis early, guide a low-tyrosine and low-phenylalanine diet, and clarify recurrence risk for relatives.
Diagnosis
Tyrosinemia type iii is usually diagnosed when blood tests show very high tyrosine levels, sometimes after symptoms such as seizures, learning delays, or balance problems raise concern, and sometimes after an unexpected newborn screening result. Getting a diagnosis is often a turning point toward answers and support. Because this condition is rare, the diagnosis of Tyrosinemia type iii usually combines clinical features with lab results and genetic confirmation.
Doctors look at symptoms, growth, and development, including whether someone has had seizures, trouble with coordination, or learning difficulties. Some people with Tyrosinemia type iii have few or no obvious symptoms, so the clinical picture can vary.
A blood test called a plasma amino acid test checks for a high tyrosine level, which is a key clue. This helps doctors see whether the body is having trouble breaking down tyrosine normally.
Urine tests may look for breakdown products that build up when tyrosine is not processed correctly. These findings can support the diagnosis and help separate Tyrosinemia type iii from other causes of high tyrosine.
Genetic tests can look for changes in the HPD gene, which is the known cause of Tyrosinemia type iii. This is often the most direct way to confirm the genetic diagnosis of Tyrosinemia type iii.
How is Tyrosinemia type iii diagnosed?
Doctors usually diagnose tyrosinemia type III with blood and urine tests that show very high levels of tyrosine, a natural substance your body gets from protein, along with other unusual chemical byproducts. They also consider the person’s symptoms, such as seizures, learning or developmental delays, or balance problems, and rule out other causes of high tyrosine. A genetic test can then help confirm the diagnosis by finding a change in the HPD gene.
Stages of Tyrosinemia type iii
Tyrosinemia type iii does not have defined progression stages. This is because it is a rare inherited condition that is usually identified by blood or urine test results, and people may have very different symptoms rather than moving through a set pattern over time. Some people have no clear day-to-day problems, while others may develop issues such as developmental delay, balance trouble, or seizures, so early symptoms of tyrosinemia type iii can vary a lot. Doctors usually start with a conversation about symptoms, family history, and development, then confirm the diagnosis with laboratory testing and, in many cases, genetic testing.
Outlook and prognosis
The outlook for people with tyrosinemia type III is generally favorable, especially when the condition is recognized early and managed with a low-tyrosine, low-phenylalanine diet when needed. Many affected individuals have mild disease or may even remain asymptomatic, while others can have neurologic features such as developmental delay, seizures, or balance problems that vary widely in severity. Because so few cases have been reported, the long-term prognosis for tyrosinemia type III is not fully defined, but severe progressive liver disease is not considered a typical feature. Mortality data are very limited, and there is no clear evidence that the disorder by itself commonly shortens life expectancy when serious neurologic complications are absent or well controlled. Ongoing follow-up with metabolic and neurologic specialists is important to monitor development, symptoms, and amino acid levels over time.
Long-term effects
For many living with tyrosinemia type iii, the long-term picture is quite variable. Some have few or no lasting health problems, while others develop ongoing brain and nerve-related effects that can affect school, work, and daily independence. Because tyrosinemia type iii is very rare, the long-term effects of tyrosinemia type iii are not mapped out as clearly as they are for more common conditions.
Some people with tyrosinemia type iii remain largely well over time and may not develop clear long-term health problems. In these cases, growth, day-to-day function, and life expectancy may be close to usual.
Some may have long-term problems with learning, attention, or intellectual development. For many, this can mean needing extra support at school in childhood and sometimes continued help with complex tasks in adult life.
Seizures can be part of the long-term picture for some people with tyrosinemia type iii. When they occur, they may come and go over time and can affect safety, driving, schooling, or independent living.
Ongoing coordination or balance difficulties may develop in some people. Many people notice small adjustments—like trouble with steady walking, sports, or quick movements—which can make physical activities harder.
How is it to live with Tyrosinemia type iii?
Living with tyrosinemia type III can look very different from one person to another: some people have few day-to-day symptoms, while others may live with developmental delays, learning difficulties, seizures, or problems with balance and coordination. For many, daily life includes regular blood tests, clinic visits, and a carefully managed low-tyrosine, low-phenylalanine diet to help keep tyrosine levels in a safer range, which can shape school, work, meals, and social routines. Families and other close supporters are often affected too, because they may help with meal planning, medical appointments, and watching for neurologic symptoms, but with steady care and support, many living with this condition can build stable routines and participate meaningfully in everyday life.
Treatment and drugs
Tyrosinemia type III is usually treated by lowering the amount of tyrosine in the body, most often with a carefully planned low-protein diet that limits tyrosine and phenylalanine, the amino acids that feed into it. For many people, treatment begins with small daily steps, such as using special medical foods or formula and working with a metabolic specialist and dietitian to keep blood levels in a safer range. Because this condition is rare, treatment is tailored to symptoms and lab results, and some people with tyrosinemia type III need regular follow-up for learning, behavior, or seizure-related concerns as well as nutrition care. Ask your doctor about the best starting point for you, especially if early symptoms of tyrosinemia type III are affecting school, energy, or day-to-day life.
Can you cure Tyrosinemia type iii?
No, there is currently no cure for tyrosinemia type III. Treatment focuses on lowering the build-up of harmful substances in the body, usually with a special low-protein eating plan and close follow-up, which can help prevent or reduce problems such as seizures, trouble with balance, or learning issues. Many people living with this condition can do well when it is found early and managed carefully.
Non-drug treatment
For many, treatment begins not at the pharmacy, but with everyday food choices and regular follow-up. In tyrosinemia type III, non-drug care is mainly aimed at lowering tyrosine levels, watching for nerve-related problems, and supporting growth and development. Because this condition is rare and symptoms can vary, care is usually tailored with help from a metabolic specialist and a dietitian.
The main non-drug treatment for tyrosinemia type III is a diet that limits tyrosine and phenylalanine, usually by reducing high-protein foods. This can help bring tyrosine levels down and may lower the chance of symptoms affecting the brain and nerves. A specialist team helps make sure nutrition stays balanced while the diet is adjusted.
A metabolic dietitian can help plan meals, choose suitable formulas or medical foods if needed, and check that children are growing well. Although making changes can feel daunting, small food swaps and clear routines often make the diet easier to follow at home, school, or work.
Ongoing blood tests are used to track tyrosine levels and see whether the diet is working. Clinic visits may also include checks for growth, learning, behavior, or signs such as seizures, especially if early symptoms of tyrosinemia type III have already appeared.
If tyrosinemia type III affects learning, movement, or speech, supportive therapies can help with day-to-day skills and school participation. This may include speech therapy, physical therapy, occupational therapy, and educational support based on the person's needs.
Your genes may have an impact on how drugs work for you
For people living with tyrosinemia type III, treatment is usually centered on a special diet rather than a medicine, so gene-based drug testing is not a routine part of care. The genetic change that causes this condition affects how the body breaks down part of protein, but it is not known to strongly guide how most commonly used medicines work for this condition. If someone with tyrosinemia type III needs medicines for related problems, such as seizures, the response can still vary from person to person, so doctors usually watch symptoms and side effects closely and adjust treatment as needed.
Pharmacological treatments
For tyrosinemia type III, there is no well-established disease-specific medicine that corrects the underlying problem. Treatment is usually centered on lowering tyrosine levels with diet rather than with drugs, because this condition is very rare and evidence on medicines is limited. If symptoms such as seizures occur, doctors may use standard medicines to control those symptoms. Not everyone responds to the same medication in the same way.
There is no approved medicine routinely used as the main treatment for tyrosinemia type III itself. For many living with tyrosinemia type III, treatment usually focuses on diet and careful follow-up rather than a disease-targeted drug.
If tyrosinemia type III causes seizures, doctors may prescribe anti-seizure drugs such as levetiracetam, valproic acid, or other standard seizure medicines based on age, symptoms, and side effects. The choice depends on the seizure type and the person’s overall health.
If there are nerve-related symptoms, treatment may include medicines aimed at symptom relief rather than the metabolic condition itself. This means the treatment for tyrosinemia type III can look different from one person to another, depending on what problems are present.
Genetic influences
Tyrosinemia type III happens because of changes in the HPD gene, which helps the body break down the amino acid tyrosine. It is an inherited condition with an autosomal recessive pattern, meaning a child must receive one changed copy of the gene from each parent to have Tyrosinemia type III. Parents are usually carriers, so they often do not have the condition themselves, but with each pregnancy there is a 25% chance of having an affected child and a 50% chance of having a child who is also a carrier. To put these pieces together, doctors may suggest genetic counseling. Genetic testing can confirm the diagnosis and can help other family members understand whether they carry the same gene change.
Is Tyrosinemia type iii genetic?
Genetics are central to Tyrosinemia type iii. It is caused by changes in the HPD gene, usually inherited from both parents. Genetic testing can confirm Tyrosinemia type iii and help with family planning.
Having a genetic risk is not necessarily a diagnosis
Gene variants are a usual part of being human and are common in the general population. Most of these variants do not directly affect health and are simply part of normal human differences. For many genes, having a variant linked to a condition points to a possible connection, not a certain diagnosis, especially when several genes and environmental factors are involved. In some cases, though, one well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
In tyrosinemia type III, the exact gene change helps confirm which form of tyrosinemia someone has, and that matters because treatment options for tyrosinemia type III are different from those for other tyrosinemia types. Many living with tyrosinemia type III are treated mainly with a diet low in tyrosine and phenylalanine, rather than with a disease-specific medicine.
This is important because a drug used for tyrosinemia type I, called nitisinone, is usually not the right treatment for tyrosinemia type III and could raise tyrosine levels even more. Not every difference in response is genetic, but in this condition the main genetic issue is the inherited change in the HPD gene that causes the enzyme problem in the first place. Genetic testing can sometimes identify how your body is affected, which helps doctors avoid the wrong treatment, monitor tyrosine levels, and tailor care if symptoms such as seizures or learning problems need separate medicines.
Interactions with other conditions
Tyrosinemia type III does not have many well-proven links with other diseases, but it can overlap with problems that affect the brain and nervous system. Some people with tyrosinemia type III may also have seizures, learning difficulties, or delays in development, and that can make the early symptoms of tyrosinemia type III easy to mistake for more common neurologic conditions. Having more than one diagnosis can make symptoms feel harder to untangle. If someone also has an illness that causes poor eating, vomiting, or dehydration, their body may have a harder time handling the amino acid imbalance that comes with tyrosinemia type III. Doctors also usually keep an eye on overall liver and kidney health, even though serious liver disease is much less typical in tyrosinemia type III than in some other forms of tyrosinemia. Because this condition is very rare, care is often most helpful when a metabolic specialist, primary doctor, and neurologist share information and follow symptoms over time.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Tyrosinemia type iii?
Since tyrosinemia type III can show up with seizures, learning delays, or trouble with balance and movement, it can be confused with other rare protein-processing conditions, especially tyrosinemia types I and II and phenylketonuria, often called PKU. Doctors may also need to rule out more common causes of these same problems, such as epilepsy and other brain or liver conditions, because the symptoms can overlap.
History
For families living with tyrosinemia type iii, the hardest part in the past was often not having a clear name for what was happening. A child might have developmental delays, learning problems, or seizures, while routine visits still left parents without firm answers. Initially understood only through symptoms, later the condition was recognized as part of a group of disorders in which the body has trouble breaking down the amino acid tyrosine.
Tyrosinemia type iii was described much later than more common childhood conditions, partly because it is so rare and can look different from one person to another. Some people with tyrosinemia type iii have clear neurologic symptoms, while others may have milder findings that are only picked up after blood and urine testing. This made the early history of tyrosinemia type iii slow to unfold, with doctors first identifying unusual chemical patterns in the body and then connecting those findings to the symptoms seen in daily life.
As medical science evolved, laboratory testing became much better at spotting small changes in amino acids and their byproducts. That helped researchers separate tyrosinemia type iii from other forms of tyrosinemia and from unrelated causes of seizures or developmental concerns. Researchers later identified a genetic cause, which confirmed that this was a distinct condition rather than a vague symptom pattern.
Today, the history of tyrosinemia type iii is still being written because so few cases have been reported worldwide. Not every early description was complete, yet together they helped doctors understand the early symptoms of tyrosinemia type iii and why careful metabolic testing matters. Knowing this history can be reassuring: even though the condition is rare, it is now better recognized, and people with tyrosinemia type iii are more likely to get a clearer diagnosis than in the past.